Medical and Pharmaceutical Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing Scribe instead wants one treatment to keep PCSK9 switched down for an extended period Joseph Morton17 hours ago
Stock News Humanoid robot demand makes Unitree’s IPO 8,000 times oversubscribed The leading firm is expecting to raise US$900M from its long-awaited public launch Rowan DunneAugust 10, 2026
Alternative Energy Westinghouse seeks U.S. IPO amid AI-driven nuclear investment boom More than half of the nuclear reactors operating worldwide use Westinghouse technology Joseph MortonJuly 31, 2026
Technology Robotic hand maker Tesollo initiates IPO proceedings Tesollo will be the first humanoid hand-dedicated firm to go public Rowan DunneJuly 9, 2026
Technology Coowa, a cleaning robotics firm worth US$3B, prepares for Hong Kong IPO The firm has deployed approximately 10,000 autonomous robots in over 50 cities Rowan DunneJune 23, 2026
AI and Autonomy Quantinuum targets USD$1.05B Nasdaq IPO in major quantum computing debut Quantinuum could achieve a fully diluted valuation near USD$12.7 billion Joseph MortonMay 27, 2026
Mining Sunshine Silver launches IPO to reopen Idaho silver-antimony mine The company is targeting an NYSE listing with a valuation of US$2.3 billion Rowan DunneMay 26, 2026
Sleep Finnish sleep tech ring maker ŌURA prepares to go public The wearable developer revealed very little in its announcement Rowan DunneMay 26, 2026
AI and Autonomy AI company Vida Global sees 81% spike after New York Stock Exchange debut Vida makes a platform for creating automated workers that communicate with clients Rowan DunneMay 21, 2026
Rare Earths Rare Earths Americas kicks off IPO, shoots for US$368M valuation Dysprosium and terbium are two of the company's primary focuses Rowan DunneApril 29, 2026